aspirin has been researched along with 8-epi-prostaglandin f2alpha in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (20.00) | 18.2507 |
| 2000's | 16 (45.71) | 29.6817 |
| 2010's | 12 (34.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anggård, EE; Betteridge, DJ; Gopaul, NK; Mallet, AI; Nourooz-Zadeh, J; Wolff, SP | 1 |
| Catella, F; Delanty, N; FitzGerald, GA; Lawson, JA; Meagher, E; Moran, N; Reilly, MP | 1 |
| Fitzgerald, GA; Lawson, JA; Pratico, D | 1 |
| Delanty, N; FitzGerald, GA; Lawson, JA; Reilly, M | 1 |
| Alessandrini, P; Bon, GB; Bucciarelli, T; Ciabattoni, G; Cipollone, F; Costantini, F; Davi, G; Mezzetti, A; Minotti, G; Patrono, C | 1 |
| Fitzgerald, GA; Kinsella, T; Lawson, J; O'Mahony, D; Pratico, D | 1 |
| Albadawi, H; Evans, JE; Humphries, DE; Kadowaki, H; Patton, GM; Soler, HM; Watkins, MT | 1 |
| Belton, O; Byrne, D; Fitzgerald, DJ; Kearney, D; Leahy, A | 1 |
| Bucciarelli, T; Ciabattoni, G; Cipollone, F; Cuccurullo, F; Davì, G; Di Gregorio, D; Pasquale, M; Patrignani, P; Patrono, C | 1 |
| Becker, BF; Heindl, B | 1 |
| Antczak, A; Barnes, PJ; Gorski, P; Kharitonov, S; Montuschi, P | 1 |
| Karowicz-Bilińska, A; Kowalska-Koprek, U; Sieroszewski, P; Suzin, J | 1 |
| Byrne, A; Cox, D; Crean, P; Fitzgerald, DJ; Kearney, D | 1 |
| Frishman, WH | 1 |
| Basu, S; Helmersson, J; Larsson, A; Vessby, B | 1 |
| Basili, S; Ciabattoni, G; Cipollone, F; Consoli, A; Davì, G; Devangelio, E; Falco, A; Mezzetti, A; Patrono, C; Santilli, F; Taraborelli, T | 1 |
| Bucciarelli, T; Ciabattoni, G; Davì, G; Del Re, L; Di Febbo, C; Di Iorio, A; Falco, A; Giusti, C; Paganelli, R; Patrono, C; Pescara, L; Porreca, E; Sau, A | 1 |
| Begum, L; Horiuchi, M; Jalil, MA; Kobayashi, K; Li, MX; Oka, T; Saheki, T; Suzuki, K; Wakamatsu, M | 1 |
| Akundi, RS; Appel, K; Bhatia, HS; Candelario-Jalil, E; Fiebich, BL; Hüll, M; Lieb, K; Muñoz, E | 1 |
| Kranzhofer, R; Ruef, J | 1 |
| Engels, F; Mortaz, E; Nijkamp, FP; Redegeld, FA | 2 |
| Ames, BN; Jiang, Q; Moreland, M; Yin, X | 1 |
| Diodati, JG; Lordkipanidzé, M; Palisaitis, DA; Pharand, C; Schampaert, E; Turgeon, J | 1 |
| Bartimoccia, S; Carnevale, R; Di Santo, S; Finocchi, A; Lenti, L; Mendolicchio, L; Pignatelli, P; Plebani, A; Sanguigni, V; Soresina, AR; Violi, F | 1 |
| Cuccurullo, C; Davì, G; Di Iorio, P; Di Michele, D; Di Ruscio, P; Ferrante, E; Lattanzio, S; Laurora, G; Lessiani, G; Liani, R; Sgrò, G; Simeone, E; Vazzana, N | 1 |
| Cherdon, C; de Leval, L; Defraigne, JO; Dogné, JM; Drion, P; Hanson, J; Masereel, B; Michiels, C; Ooms, A; Pirotte, B; Rolin, S; Sakalihassan, N | 1 |
| Gajos, G; Nessler, J; Piwowarska, W; Rostoff, P; Undas, A; Zalewski, J | 1 |
| Basu, S; Berg, K; Ericsson, M; Haaverstad, R; Langaas, M; Nordrum, IS; Pleym, H; Vitale, N | 1 |
| Davì, G; Di Marco, M; Di Nicola, M; La Barba, S; Lattanzio, S; Liani, R; Mascellanti, M; Paloscia, L; Pascale, S; Santilli, F | 1 |
| Blanchard, HC; Rapoport, SI; Taha, AY; Yuan, ZX | 1 |
| Cavalca, V; Ciaffardini, F; Ciminello, A; Habib, A; Pagliaccia, F; Patrono, C; Petrucci, G; Pitocco, D; Rizzi, A; Rizzo, P; Rocca, B; Squellerio, I; Tanese, L; Tremoli, E; Zaccardi, F | 1 |
| Bennett-Firmin, J; Bottiglieri, T; Lopez, LR; McCullough, PA; Peterson, M; Schiffmann, R; Swift, C; Vasudevan, A | 1 |
| Bennett-Firmin, J; Bottiglieri, T; Lopez, LR; McCullough, PA; Peterson, M; Sathyamoorthy, M; Schiffmann, R; Schussler, JM; Swift, C; Tecson, KM; Vasudevan, A; Velasco, CE | 1 |
| Feng, J; Guo, J; Wang, J | 1 |
2 review(s) available for aspirin and 8-epi-prostaglandin f2alpha
| Article | Year |
|---|---|
New insights on the possible role of mast cells in aspirin-induced asthma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Asthma, Aspirin-Induced; Dinoprost; HSP70 Heat-Shock Proteins; Humans; Leukotrienes; Mast Cells; Phosphoric Monoester Hydrolases; Prostaglandin-Endoperoxide Synthases; Toll-Like Receptors | 2009 |
Aspirin resistance mediated by oxidative stress-induced 8-Isoprostaglandin F2.
Topics: Aspirin; Dinoprost; Drug Resistance; Humans; Oxidative Stress | 2019 |
10 trial(s) available for aspirin and 8-epi-prostaglandin f2alpha
| Article | Year |
|---|---|
Physiological formation of 8-epi-PGF2 alpha in vivo is not affected by cyclooxygenase inhibition.
Topics: Acetaminophen; Aspirin; Cross-Over Studies; Cyclooxygenase Inhibitors; Dinoprost; Double-Blind Method; Fatty Acids, Monounsaturated; Gas Chromatography-Mass Spectrometry; Humans; Oxygen Isotopes; Platelet Aggregation Inhibitors; Smoking | 1995 |
Modulation of oxidant stress in vivo in chronic cigarette smokers.
Topics: Administration, Cutaneous; Adolescent; Adult; Antioxidants; Ascorbic Acid; Aspirin; Cross-Sectional Studies; Dinoprost; Dose-Response Relationship, Drug; F2-Isoprostanes; Humans; Middle Aged; Nicotine; Oxidative Stress; Smoking; Thromboxane B2; Vitamin E | 1996 |
Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprost; Epoprostenol; F2-Isoprostanes; Female; Humans; Isoenzymes; Macrophages; Male; Membrane Proteins; Microscopy, Fluorescence; Muscle, Smooth, Vascular; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Thromboxane A2; Thromboxane B2 | 2000 |
Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina.
Topics: Angina, Unstable; Antioxidants; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprost; Dose-Response Relationship, Drug; Drug Resistance; F2-Isoprostanes; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Oxidative Stress; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Thromboxane A2; Time Factors | 2000 |
Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Biphenyl Compounds; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprost; Epoprostenol; Female; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Peroxidases; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prostaglandin-Endoperoxide Synthases; Pyrrolidines; Sulfonamides; Thromboxane A2 | 2004 |
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
Topics: Aged; Aspirin; CD40 Ligand; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Dinoprost; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Platelet Activation; Platelet Aggregation Inhibitors; Radioimmunoassay; Thromboxane A2; Thromboxane B2 | 2006 |
Determinants of platelet activation in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Aspirin; Body Mass Index; C-Reactive Protein; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Cyclooxygenase 2 Inhibitors; Dinoprost; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukin-6; Lactones; Logistic Models; Male; Odds Ratio; Platelet Activation; Radioimmunoassay; Sulfones; Thromboxane B2; Tumor Necrosis Factor-alpha; Vitamin E | 2007 |
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost.
Topics: Aged; Aged, 80 and over; Aspirin; Biomarkers; Blood Platelets; CD40 Ligand; Chi-Square Distribution; Critical Illness; Dinoprost; Drug Administration Schedule; Female; Humans; Iloprost; Inflammation Mediators; Infusions, Intravenous; Ischemia; Italy; Lipid Peroxidation; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Platelet Activation; Platelet Aggregation Inhibitors; Thromboxane B2; Time Factors; Treatment Outcome | 2011 |
Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI clot).
Topics: Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; Blood Coagulation; C-Reactive Protein; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Dinoprost; Double-Blind Method; Down-Regulation; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Fibrin; Humans; Linear Models; Male; Middle Aged; Oxidative Stress; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Poland; Prospective Studies; Prothrombin; Thrombin; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2011 |
Acetylsalicylic acid treatment until surgery reduces oxidative stress and inflammation in patients undergoing coronary artery bypass grafting.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; C-Reactive Protein; Coronary Artery Bypass; Dinoprost; Drug Administration Schedule; Female; Humans; Inflammation; Male; Middle Aged; Oxidative Stress; Postoperative Hemorrhage; Prospective Studies; Troponin T | 2013 |
23 other study(ies) available for aspirin and 8-epi-prostaglandin f2alpha
| Article | Year |
|---|---|
Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus.
Topics: Adult; Aspirin; Chromatography, Gas; Diabetes Mellitus, Type 2; Dinoprost; Esterification; Humans; Indomethacin; Mass Spectrometry; Models, Chemical; Oxidative Stress | 1995 |
Cyclooxygenase-dependent formation of the isoprostane 8-epi prostaglandin F2 alpha.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Aspirin; Blood Platelets; Dinoprost; Humans; Hydroxyeicosatetraenoic Acids; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Thromboxane B2 | 1994 |
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.
Topics: Antioxidants; Aspirin; Cardiovascular Diseases; Cross-Sectional Studies; Cyclooxygenase Inhibitors; Dinoprost; Female; Humans; Hypercholesterolemia; Isoindoles; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Phenylbutyrates; Platelet Activation; Platelet Aggregation Inhibitors; Reactive Oxygen Species; Thromboxane B2; Vitamin E | 1997 |
Cellular activation by thromboxane A2 and 8-EPI-PGF2 alpha.
Topics: Animals; Aspirin; Cell Line; Cyclic AMP-Dependent Protein Kinases; Dinoprost; Humans; Point Mutation; Protein Kinase C; Receptors, Thromboxane; Recombinant Proteins; Thromboxane A2; Transfection; Vasoconstrictor Agents | 1997 |
Synthesis of 8-epi-prostaglandin F2alpha by human endothelial cells: role of prostaglandin H2 synthase.
Topics: Animals; Aspirin; Catalase; Cell Hypoxia; Cells, Cultured; COS Cells; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Endothelium, Vascular; Free Radical Scavengers; Humans; Hydrogen Peroxide; Indomethacin; Lipids; Mass Spectrometry; Prostaglandin-Endoperoxide Synthases; Reactive Oxygen Species; Superoxide Dismutase; Umbilical Arteries | 1999 |
Aspirin, but not the more selective cyclooxygenase (COX)-2 inhibitors meloxicam and SC 58125, aggravates postischaemic cardiac dysfunction, independent of COX function.
Topics: Animals; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprost; Eicosanoids; F2-Isoprostanes; Guinea Pigs; Heart; Hemodynamics; Isoenzymes; Male; Meloxicam; Myocardial Ischemia; Myocardial Reperfusion Injury; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Thiazines; Thiazoles; Thromboxane A2 | 2001 |
Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Breath Tests; Cysteine; Dinoprost; Dinoprostone; F2-Isoprostanes; Female; Humans; Inflammation Mediators; Leukotriene B4; Leukotrienes; Male; Middle Aged; Oxidative Stress; Oxytocics; Respiratory System; Vasoconstrictor Agents | 2002 |
[Analysis of 8-isoprostane concentration as a marker of oxidative stress in pregnant women diagnosed with IUGR].
Topics: Adult; Arginine; Aspirin; Biomarkers; Case-Control Studies; Dinoprost; F2-Isoprostanes; Female; Fetal Blood; Fetal Growth Retardation; Humans; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Poland; Pregnancy; Retrospective Studies; Statistics, Nonparametric; Time Factors; Treatment Outcome | 2003 |
Cyclooxygenase inhibition in patients with coronary artery disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Artery Disease; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprost; Humans; Isoenzymes; Membrane Proteins; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Thromboxane A2 | 2004 |
Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population.
Topics: Aged; alpha-Tocopherol; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Cohort Studies; Comorbidity; Diabetes Mellitus, Type 2; Dinoprost; Follow-Up Studies; Humans; Inflammation; Insulin; Lipids; Male; Oxidative Stress; Prostaglandin-Endoperoxide Synthases; Serum Amyloid A Protein; Sweden | 2004 |
Attenuation of cardiac hypertrophy in carnitine-deficient juvenile visceral steatosis (JVS) mice achieved by lowering dietary lipid.
Topics: Animals; Aspirin; Carnitine; Diet; Dinoprost; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypertrophy, Left Ventricular; Lipids; Male; Mice; Mice, Mutant Strains; Vitamin B Deficiency | 2006 |
Ascorbic acid enhances the inhibitory effect of aspirin on neuronal cyclooxygenase-2-mediated prostaglandin E2 production.
Topics: Antioxidants; Ascorbic Acid; Aspirin; Blotting, Western; Cell Line, Tumor; Cyclooxygenase 2; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression; Humans; Interleukin-1; Neural Inhibition; Neuroblastoma; Neurons | 2006 |
Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism.
Topics: Antigens, Neoplasm; Aspirin; Blood Platelets; Coronary Artery Disease; Cyclooxygenase 1; Dinoprost; Drug Resistance; Humans; Integrin beta3; Lipid Peroxidation; Nephelometry and Turbidimetry; Oxidative Stress; Platelet Aggregation; Polymorphism, Genetic; Polymorphism, Single Nucleotide; RNA, Messenger; Thromboxane A2; Thromboxane B2 | 2006 |
Aspirin induces the production of the inflammatory mediator 8-epi-PGF in mast cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Cells, Cultured; Dinitrophenols; Dinoprost; Dose-Response Relationship, Drug; Hydrogen Peroxide; Immunoglobulin E; Inflammation Mediators; Mast Cells; Mice; Mice, Inbred BALB C; Pyrrolidines; Reactive Oxygen Species; Serum Albumin; Thiocarbamates | 2006 |
A combination of aspirin and gamma-tocopherol is superior to that of aspirin and alpha-tocopherol in anti-inflammatory action and attenuation of aspirin-induced adverse effects.
Topics: alpha-Tocopherol; Animals; Anti-Inflammatory Agents; Aspirin; Carrageenan; Dinoprost; Dinoprostone; Drug Therapy, Combination; Eating; gamma-Tocopherol; Gastric Mucosa; Inflammation; Male; Rats; Rats, Wistar; Vitamin E | 2009 |
Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin.
Topics: Aged; Aspirin; Blood Platelets; Coronary Artery Disease; Dinoprost; Drug Resistance; Female; Humans; Male; Middle Aged; Oxidative Stress; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Risk Factors; Thromboembolism; Treatment Failure | 2010 |
Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction.
Topics: Adult; Aspirin; Blood Platelets; Calcium; Case-Control Studies; Deficiency Diseases; Dinoprost; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Isoprostanes; Male; Membrane Glycoproteins; NADP; NADPH Oxidase 2; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 2011 |
BM-573 inhibits the development of early atherosclerotic lesions in Apo E deficient mice by blocking TP receptors and thromboxane synthase.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Apolipoproteins E; Aspirin; Atherosclerosis; Dinoprost; Drug Therapy, Combination; Endothelial Cells; Humans; Intercellular Adhesion Molecule-1; Mice; Mice, Knockout; Receptors, Thromboxane; Saphenous Vein; Sulfonylurea Compounds; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Vascular Cell Adhesion Molecule-1 | 2011 |
Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Calgranulin A; Calgranulin B; Chronic Disease; Dinoprost; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Activation; Platelet Aggregation Inhibitors; Thromboxane B2 | 2014 |
Low-dose aspirin (acetylsalicylate) prevents increases in brain PGE2, 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats, a model for HIV-1 associated neurocognitive disorders.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain; Dinoprost; Dinoprostone; Disease Models, Animal; HIV-1; Lipoxins; Male; Neurocognitive Disorders; Rats; Rats, Transgenic; Vasoconstrictor Agents | 2015 |
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes.
Topics: Adult; Albuminuria; Aspirin; Blood Glucose; Cross-Sectional Studies; Cyclooxygenase 1; Diabetes Mellitus, Type 1; Dinoprost; Epoprostenol; Female; Humans; Male; Matched-Pair Analysis; Microvessels; Middle Aged; Oxidative Stress; Platelet Activation; Platelet Aggregation Inhibitors; Sex Factors; Thromboxane A2 | 2016 |
Oxidative stress reflected by increased F
Topics: Aged; Aspirin; Coronary Artery Disease; Cross-Sectional Studies; Cyclooxygenase 1; Dinoprost; F2-Isoprostanes; Female; Humans; Male; Middle Aged; Oxidative Stress; Platelet Aggregation Inhibitors; Thromboxane B2 | 2016 |
Residual thromboxane activity and oxidative stress: influence on mortality in patients with stable coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Cause of Death; Coronary Artery Disease; Cyclooxygenase Inhibitors; Dinoprost; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oxidative Stress; Prognosis; Prospective Studies; Risk Factors; Survival Rate; Texas; Thromboxane B2; Time Factors | 2017 |